Richmond Brothers, Inc. Ocuphire Pharma, Inc. Transaction History
Richmond Brothers, Inc.
- $52.6 Million
- Q1 2024
A detailed history of Richmond Brothers, Inc. transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Richmond Brothers, Inc. holds 227,461 shares of OCUP stock, worth $348,015. This represents 0.87% of its overall portfolio holdings.
Number of Shares
227,461
Previous 252,769
10.01%
Holding current value
$348,015
Previous $760,000
39.87%
% of portfolio
0.87%
Previous 1.34%
Shares
10 transactions
Others Institutions Holding OCUP
# of Institutions
52Shares Held
3.42MCall Options Held
3.6KPut Options Held
6.2K-
Vanguard Group Inc Valley Forge, PA992KShares$1.52 Million0.0% of portfolio
-
Rice Hall James & Associates, LLC292KShares$446,7370.04% of portfolio
-
Geode Capital Management, LLC Boston, MA234KShares$358,6280.0% of portfolio
-
Mai Capital Management224KShares$342,6740.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX210KShares$321,2090.01% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $31.5M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...